Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.87302599 |
2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.87302599 |
3 | detection of other organism (GO:0098543) | 4.70001527 |
4 | leukocyte aggregation (GO:0070486) | 4.65079242 |
5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.54598214 |
6 | detection of bacterium (GO:0016045) | 4.50162352 |
7 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.47583116 |
8 | detection of external biotic stimulus (GO:0098581) | 4.05328159 |
9 | detection of molecule of bacterial origin (GO:0032490) | 3.96591794 |
10 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.82011319 |
11 | negative regulation of cell killing (GO:0031342) | 3.73357484 |
12 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.73357484 |
13 | positive regulation by symbiont of host defense response (GO:0052509) | 3.67753464 |
14 | modulation by symbiont of host defense response (GO:0052031) | 3.67753464 |
15 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.67753464 |
16 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.67753464 |
17 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.67753464 |
18 | modulation by symbiont of host immune response (GO:0052553) | 3.67753464 |
19 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.61468385 |
20 | positive thymic T cell selection (GO:0045059) | 3.59128953 |
21 | regulation of mast cell degranulation (GO:0043304) | 3.58138445 |
22 | detection of biotic stimulus (GO:0009595) | 3.54743753 |
23 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.53472043 |
24 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.50247760 |
25 | regulation of gamma-delta T cell activation (GO:0046643) | 3.48835163 |
26 | negative regulation of interleukin-12 production (GO:0032695) | 3.47633430 |
27 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.45186622 |
28 | germinal center formation (GO:0002467) | 3.45001187 |
29 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.39302334 |
30 | regulation of leukocyte degranulation (GO:0043300) | 3.36383042 |
31 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.34424737 |
32 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.33084048 |
33 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.32368722 |
34 | myeloid cell activation involved in immune response (GO:0002275) | 3.28541647 |
35 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.27546192 |
36 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.24057501 |
37 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.21685205 |
38 | macrophage activation (GO:0042116) | 3.19871175 |
39 | leukocyte cell-cell adhesion (GO:0007159) | 3.17568663 |
40 | cellular extravasation (GO:0045123) | 3.15495623 |
41 | NIK/NF-kappaB signaling (GO:0038061) | 3.12181056 |
42 | response to peptidoglycan (GO:0032494) | 3.12034048 |
43 | immunoglobulin mediated immune response (GO:0016064) | 3.06261108 |
44 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.05648026 |
45 | microglial cell activation (GO:0001774) | 3.04662188 |
46 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.04210993 |
47 | negative regulation of T cell mediated immunity (GO:0002710) | 3.02840560 |
48 | tolerance induction (GO:0002507) | 3.01859277 |
49 | regulation of T cell tolerance induction (GO:0002664) | 3.01716408 |
50 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.01268073 |
51 | neutrophil mediated immunity (GO:0002446) | 3.00563236 |
52 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.00541640 |
53 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.99174534 |
54 | response to muramyl dipeptide (GO:0032495) | 2.99030425 |
55 | hepatocyte apoptotic process (GO:0097284) | 2.97794341 |
56 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.96579219 |
57 | positive regulation of mast cell activation (GO:0033005) | 2.92757161 |
58 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.92528057 |
59 | thymic T cell selection (GO:0045061) | 2.92222838 |
60 | defense response to protozoan (GO:0042832) | 2.91702529 |
61 | positive regulation of histone deacetylation (GO:0031065) | 2.90427906 |
62 | negative thymic T cell selection (GO:0045060) | 2.90203561 |
63 | regulation of tolerance induction (GO:0002643) | 2.89436499 |
64 | negative regulation of phagocytosis (GO:0050765) | 2.88608062 |
65 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.88336081 |
66 | regulation of mast cell activation (GO:0033003) | 2.86753928 |
67 | cellular response to interleukin-15 (GO:0071350) | 2.85661859 |
68 | response to laminar fluid shear stress (GO:0034616) | 2.84119609 |
69 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.84098466 |
70 | negative T cell selection (GO:0043383) | 2.83539433 |
71 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.82752232 |
72 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.82483421 |
73 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.80606090 |
74 | regulation of regulated secretory pathway (GO:1903305) | 2.78528224 |
75 | respiratory burst (GO:0045730) | 2.77587144 |
76 | leukocyte degranulation (GO:0043299) | 2.76722544 |
77 | T cell migration (GO:0072678) | 2.74416914 |
78 | negative regulation of interleukin-6 production (GO:0032715) | 2.72689425 |
79 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.72442829 |
80 | neutrophil activation involved in immune response (GO:0002283) | 2.72014155 |
81 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.68478302 |
82 | regulation of B cell differentiation (GO:0045577) | 2.67966634 |
83 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.66911003 |
84 | T-helper 1 type immune response (GO:0042088) | 2.66475991 |
85 | myeloid leukocyte activation (GO:0002274) | 2.66124787 |
86 | morphogenesis of an endothelium (GO:0003159) | 2.66069034 |
87 | endothelial tube morphogenesis (GO:0061154) | 2.66069034 |
88 | negative regulation of innate immune response (GO:0045824) | 2.65581614 |
89 | B cell receptor signaling pathway (GO:0050853) | 2.65334653 |
90 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.63561175 |
91 | response to fungus (GO:0009620) | 2.63359022 |
92 | neutrophil chemotaxis (GO:0030593) | 2.62864606 |
93 | T cell apoptotic process (GO:0070231) | 2.62743444 |
94 | response to interleukin-15 (GO:0070672) | 2.62534333 |
95 | regulation of podosome assembly (GO:0071801) | 2.62318456 |
96 | actin nucleation (GO:0045010) | 2.61552093 |
97 | B cell mediated immunity (GO:0019724) | 2.60385405 |
98 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.59594600 |
99 | positive regulation of B cell differentiation (GO:0045579) | 2.59055393 |
100 | positive regulation of interferon-alpha production (GO:0032727) | 2.57811716 |
101 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.57341119 |
102 | neutrophil activation (GO:0042119) | 2.56487561 |
103 | response to host (GO:0075136) | 2.56311679 |
104 | response to host defenses (GO:0052200) | 2.56311679 |
105 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.56311679 |
106 | regulation of response to interferon-gamma (GO:0060330) | 2.55456271 |
107 | positive T cell selection (GO:0043368) | 2.54580997 |
108 | positive regulation of lamellipodium assembly (GO:0010592) | 2.53259719 |
109 | response to host immune response (GO:0052572) | 2.53077626 |
110 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.53077626 |
111 | defense response to fungus (GO:0050832) | 2.51797017 |
112 | regulation of interferon-alpha production (GO:0032647) | 2.51472318 |
113 | granulocyte activation (GO:0036230) | 2.51236708 |
114 | T cell selection (GO:0045058) | 2.50056567 |
115 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.47611978 |
116 | macrophage activation involved in immune response (GO:0002281) | 2.46656958 |
117 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.43541706 |
118 | apoptotic process involved in morphogenesis (GO:0060561) | 2.43527050 |
119 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.41537387 |
120 | positive regulation of isotype switching (GO:0045830) | 2.40769511 |
121 | response to type I interferon (GO:0034340) | 2.39776390 |
122 | regulation of protein heterodimerization activity (GO:0043497) | 2.39699264 |
123 | interferon-gamma production (GO:0032609) | 2.38860365 |
124 | myeloid dendritic cell differentiation (GO:0043011) | 2.38691627 |
125 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.37115551 |
126 | positive regulation of tolerance induction (GO:0002645) | 2.35672956 |
127 | establishment of endothelial barrier (GO:0061028) | 2.35570468 |
128 | type I interferon signaling pathway (GO:0060337) | 2.33316957 |
129 | cellular response to type I interferon (GO:0071357) | 2.33316957 |
130 | positive regulation of protein deacetylation (GO:0090312) | 2.32213699 |
131 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.31807650 |
132 | lymphocyte apoptotic process (GO:0070227) | 2.31650235 |
133 | myeloid dendritic cell activation (GO:0001773) | 2.31394514 |
134 | T cell costimulation (GO:0031295) | 2.30439411 |
135 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.30021179 |
136 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.29748476 |
137 | response to protozoan (GO:0001562) | 2.28950635 |
138 | natural killer cell differentiation (GO:0001779) | 2.27459057 |
139 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.25474857 |
140 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.25424661 |
141 | positive regulation of lamellipodium organization (GO:1902745) | 2.25139787 |
142 | lymphocyte costimulation (GO:0031294) | 2.24993207 |
143 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.24860671 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.85877960 |
2 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.61824871 |
3 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.16335046 |
4 | MYC_22102868_ChIP-Seq_BL_Human | 3.16006213 |
5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.03795059 |
6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.94964125 |
7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.94877247 |
8 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.70815974 |
9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.68200308 |
10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.57864368 |
11 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.55395599 |
12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.42533745 |
13 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.42283258 |
14 | MAF_26560356_Chip-Seq_TH1_Human | 2.28601296 |
15 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.19669968 |
16 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.14473711 |
17 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.10667255 |
18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.10039330 |
19 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.07542279 |
20 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.07128534 |
21 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.06446588 |
22 | MYB_26560356_Chip-Seq_TH2_Human | 2.02542059 |
23 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.02529428 |
24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.01165942 |
25 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.00416424 |
26 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.97011351 |
27 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.96785601 |
28 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.92225099 |
29 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.90805571 |
30 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.90791004 |
31 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.90397740 |
32 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.89324043 |
33 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.87360052 |
34 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.84031471 |
35 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.81091747 |
36 | * MYB_26560356_Chip-Seq_TH1_Human | 1.80928988 |
37 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.80160476 |
38 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.79751208 |
39 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.77946640 |
40 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.75167208 |
41 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75041243 |
42 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.74868766 |
43 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.74407750 |
44 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.67688492 |
45 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.66444324 |
46 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.65078085 |
47 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.64936453 |
48 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.64008512 |
49 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.63908443 |
50 | * MAF_26560356_Chip-Seq_TH2_Human | 1.48123750 |
51 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.47959749 |
52 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.44028706 |
53 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.41636275 |
54 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.40156461 |
55 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38495371 |
56 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.37910135 |
57 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28211349 |
58 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.24180440 |
59 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.22747278 |
60 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.22168762 |
61 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.21240634 |
62 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.20416853 |
63 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19270631 |
64 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19239073 |
65 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18299151 |
66 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.18114830 |
67 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.17282664 |
68 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.14963238 |
69 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.14722425 |
70 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14231048 |
71 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.12696802 |
72 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.12681681 |
73 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.12212570 |
74 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.11942727 |
75 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11648092 |
76 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11554161 |
77 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.11105761 |
78 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.10991337 |
79 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.10813720 |
80 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09727123 |
81 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09366402 |
82 | GATA1_22025678_ChIP-Seq_K562_Human | 1.08136594 |
83 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.07279386 |
84 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.06892055 |
85 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.06284012 |
86 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05585796 |
87 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05530674 |
88 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04570713 |
89 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.03755670 |
90 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03735110 |
91 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.03306454 |
92 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02840192 |
93 | KDM2B_26808549_Chip-Seq_K562_Human | 1.02784072 |
94 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.00687113 |
95 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.99724285 |
96 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99544571 |
97 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.99158529 |
98 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.98276491 |
99 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.98213590 |
100 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.97705349 |
101 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.95963937 |
102 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95619789 |
103 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.95541416 |
104 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.94749362 |
105 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.93094897 |
106 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.92837280 |
107 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.92274073 |
108 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.90895849 |
109 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90582103 |
110 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.90431284 |
111 | GATA2_19941826_ChIP-Seq_K562_Human | 0.89431349 |
112 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.87326606 |
113 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.86797989 |
114 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.86762887 |
115 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.86346195 |
116 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.86044329 |
117 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.85899306 |
118 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85866447 |
119 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.85376783 |
120 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85198018 |
121 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.85025331 |
122 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.85025331 |
123 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.84898410 |
124 | GATA1_19941826_ChIP-Seq_K562_Human | 0.84703830 |
125 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.84437658 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003303_peritoneal_inflammation | 3.53706556 |
2 | MP0003436_decreased_susceptibility_to | 2.89033869 |
3 | MP0003300_gastrointestinal_ulcer | 2.74745620 |
4 | MP0001835_abnormal_antigen_presentation | 2.67113425 |
5 | MP0000685_abnormal_immune_system | 2.64674516 |
6 | MP0010352_gastrointestinal_tract_polyps | 2.52889697 |
7 | MP0009278_abnormal_bone_marrow | 2.50133419 |
8 | MP0009785_altered_susceptibility_to | 2.42758816 |
9 | MP0001800_abnormal_humoral_immune | 2.37761054 |
10 | MP0001790_abnormal_immune_system | 2.32641951 |
11 | MP0005387_immune_system_phenotype | 2.32641951 |
12 | MP0005451_abnormal_body_composition | 2.21626011 |
13 | MP0005000_abnormal_immune_tolerance | 2.21194978 |
14 | MP0002452_abnormal_antigen_presenting | 2.19391933 |
15 | MP0005025_abnormal_response_to | 2.09458365 |
16 | MP0005671_abnormal_response_to | 2.07187813 |
17 | MP0008260_abnormal_autophagy | 2.05708793 |
18 | MP0002405_respiratory_system_inflammati | 2.04435766 |
19 | MP0003705_abnormal_hypodermis_morpholog | 2.04003932 |
20 | MP0002420_abnormal_adaptive_immunity | 2.03380855 |
21 | MP0001819_abnormal_immune_cell | 2.02510078 |
22 | MP0002419_abnormal_innate_immunity | 2.01872212 |
23 | MP0002723_abnormal_immune_serum | 2.01864222 |
24 | MP0004947_skin_inflammation | 2.01606744 |
25 | MP0003763_abnormal_thymus_physiology | 2.00825055 |
26 | MP0003566_abnormal_cell_adhesion | 1.99517255 |
27 | MP0010155_abnormal_intestine_physiology | 1.94999213 |
28 | MP0005076_abnormal_cell_differentiation | 1.89663339 |
29 | * MP0002398_abnormal_bone_marrow | 1.86857402 |
30 | MP0009333_abnormal_splenocyte_physiolog | 1.85741664 |
31 | MP0001873_stomach_inflammation | 1.85154159 |
32 | MP0004510_myositis | 1.79426648 |
33 | MP0006082_CNS_inflammation | 1.74773886 |
34 | MP0002396_abnormal_hematopoietic_system | 1.73553276 |
35 | MP0004808_abnormal_hematopoietic_stem | 1.71889305 |
36 | MP0005397_hematopoietic_system_phenotyp | 1.69102385 |
37 | MP0001545_abnormal_hematopoietic_system | 1.69102385 |
38 | MP0000716_abnormal_immune_system | 1.66771371 |
39 | MP0005023_abnormal_wound_healing | 1.64188351 |
40 | MP0000858_altered_metastatic_potential | 1.61949086 |
41 | MP0002148_abnormal_hypersensitivity_rea | 1.61362712 |
42 | * MP0005464_abnormal_platelet_physiology | 1.59265130 |
43 | MP0000490_abnormal_crypts_of | 1.56999754 |
44 | MP0001533_abnormal_skeleton_physiology | 1.56932910 |
45 | MP0002722_abnormal_immune_system | 1.56819346 |
46 | MP0003448_altered_tumor_morphology | 1.55909980 |
47 | MP0000689_abnormal_spleen_morphology | 1.55097391 |
48 | MP0001845_abnormal_inflammatory_respons | 1.53605815 |
49 | MP0002166_altered_tumor_susceptibility | 1.53130890 |
50 | MP0003724_increased_susceptibility_to | 1.50313388 |
51 | MP0002429_abnormal_blood_cell | 1.46963479 |
52 | MP0003075_altered_response_to | 1.43236092 |
53 | MP0000465_gastrointestinal_hemorrhage | 1.42686919 |
54 | MP0010307_abnormal_tumor_latency | 1.41373892 |
55 | MP0003866_abnormal_defecation | 1.40696450 |
56 | MP0001853_heart_inflammation | 1.39922124 |
57 | MP0003453_abnormal_keratinocyte_physiol | 1.35843074 |
58 | MP0002132_abnormal_respiratory_system | 1.34154288 |
59 | MP0002006_tumorigenesis | 1.30789907 |
60 | MP0000703_abnormal_thymus_morphology | 1.29015052 |
61 | MP0002933_joint_inflammation | 1.27931592 |
62 | MP0010234_abnormal_vibrissa_follicle | 1.27472578 |
63 | MP0006054_spinal_hemorrhage | 1.20744758 |
64 | MP0004883_abnormal_blood_vessel | 1.19550297 |
65 | MP0005058_abnormal_lysosome_morphology | 1.19239912 |
66 | MP0000343_altered_response_to | 1.18752013 |
67 | MP0003091_abnormal_cell_migration | 1.16594163 |
68 | MP0005164_abnormal_response_to | 1.11685189 |
69 | MP0002877_abnormal_melanocyte_morpholog | 1.10702369 |
70 | MP0002254_reproductive_system_inflammat | 1.10535536 |
71 | MP0003183_abnormal_peptide_metabolism | 1.08466883 |
72 | MP0003693_abnormal_embryo_hatching | 1.06995238 |
73 | MP0008469_abnormal_protein_level | 1.02698588 |
74 | MP0008004_abnormal_stomach_pH | 1.01740715 |
75 | MP0003828_pulmonary_edema | 1.00135437 |
76 | MP0000604_amyloidosis | 0.98753413 |
77 | MP0004381_abnormal_hair_follicle | 0.98191509 |
78 | MP0002019_abnormal_tumor_incidence | 0.97951372 |
79 | MP0001851_eye_inflammation | 0.97760283 |
80 | MP0009840_abnormal_foam_cell | 0.97184767 |
81 | MP0003279_aneurysm | 0.96846279 |
82 | MP0002277_abnormal_respiratory_mucosa | 0.93989920 |
83 | MP0005310_abnormal_salivary_gland | 0.91579945 |
84 | MP0000733_abnormal_muscle_development | 0.91119632 |
85 | MP0003806_abnormal_nucleotide_metabolis | 0.89666848 |
86 | MP0001958_emphysema | 0.89447737 |
87 | MP0004957_abnormal_blastocyst_morpholog | 0.87188282 |
88 | MP0003191_abnormal_cellular_cholesterol | 0.86367528 |
89 | MP0003172_abnormal_lysosome_physiology | 0.86265109 |
90 | MP0003077_abnormal_cell_cycle | 0.86115535 |
91 | MP0002998_abnormal_bone_remodeling | 0.85814468 |
92 | MP0000477_abnormal_intestine_morphology | 0.85776351 |
93 | MP0004858_abnormal_nervous_system | 0.83896149 |
94 | MP0009763_increased_sensitivity_to | 0.82193441 |
95 | MP0000350_abnormal_cell_proliferation | 0.81671312 |
96 | MP0005390_skeleton_phenotype | 0.80729585 |
97 | MP0002086_abnormal_extraembryonic_tissu | 0.80614502 |
98 | MP0001663_abnormal_digestive_system | 0.79621796 |
99 | MP0005167_abnormal_blood-brain_barrier | 0.78682387 |
100 | MP0003656_abnormal_erythrocyte_physiolo | 0.78124823 |
101 | MP0001730_embryonic_growth_arrest | 0.76401190 |
102 | MP0003045_fibrosis | 0.76238413 |
103 | MP0003690_abnormal_glial_cell | 0.76043035 |
104 | MP0001849_ear_inflammation | 0.75377289 |
105 | MP0004185_abnormal_adipocyte_glucose | 0.74708727 |
106 | MP0003111_abnormal_nucleus_morphology | 0.74426213 |
107 | MP0009764_decreased_sensitivity_to | 0.73260002 |
108 | MP0001216_abnormal_epidermal_layer | 0.72760072 |
109 | MP0000767_abnormal_smooth_muscle | 0.72113352 |
110 | MP0000249_abnormal_blood_vessel | 0.71379331 |
111 | MP0004264_abnormal_extraembryonic_tissu | 0.71358643 |
112 | MP0002138_abnormal_hepatobiliary_system | 0.70476693 |
113 | MP0005166_decreased_susceptibility_to | 0.70017951 |
114 | MP0008438_abnormal_cutaneous_collagen | 0.67780979 |
115 | MP0003221_abnormal_cardiomyocyte_apopto | 0.66005752 |
116 | MP0003795_abnormal_bone_structure | 0.64982136 |
117 | MP0009931_abnormal_skin_appearance | 0.64720566 |
118 | MP0002925_abnormal_cardiovascular_devel | 0.64325199 |
119 | MP0008874_decreased_physiological_sensi | 0.62814153 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 5.14954401 |
2 | Recurrent abscess formation (HP:0002722) | 4.48885698 |
3 | Recurrent bacterial skin infections (HP:0005406) | 3.78049895 |
4 | Recurrent fungal infections (HP:0002841) | 3.52709789 |
5 | Pustule (HP:0200039) | 3.47263136 |
6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.43276470 |
7 | Myositis (HP:0100614) | 3.30071548 |
8 | Cellulitis (HP:0100658) | 3.18051108 |
9 | Recurrent viral infections (HP:0004429) | 3.12079844 |
10 | Nasal polyposis (HP:0100582) | 3.09524612 |
11 | Increased density of long bones (HP:0006392) | 3.09101767 |
12 | Mediastinal lymphadenopathy (HP:0100721) | 3.07584678 |
13 | Interstitial pulmonary disease (HP:0006530) | 3.00853271 |
14 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.99293989 |
15 | Keratoconjunctivitis sicca (HP:0001097) | 2.99024426 |
16 | Abnormality of macrophages (HP:0004311) | 2.96920233 |
17 | Abnormality of the nasal mucosa (HP:0000433) | 2.96147729 |
18 | Chronic otitis media (HP:0000389) | 2.95768815 |
19 | IgM deficiency (HP:0002850) | 2.89950757 |
20 | Autoimmune thrombocytopenia (HP:0001973) | 2.89624551 |
21 | Encephalitis (HP:0002383) | 2.89588110 |
22 | Stomatitis (HP:0010280) | 2.88625390 |
23 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.84789433 |
24 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.84789433 |
25 | Abnormality of glycolipid metabolism (HP:0010969) | 2.84789433 |
26 | Chronic obstructive pulmonary disease (HP:0006510) | 2.75728721 |
27 | Obstructive lung disease (HP:0006536) | 2.75728721 |
28 | Recurrent bronchitis (HP:0002837) | 2.74758810 |
29 | Inflammation of the large intestine (HP:0002037) | 2.72933284 |
30 | Keratoconjunctivitis (HP:0001096) | 2.72249679 |
31 | Gastrointestinal inflammation (HP:0004386) | 2.71815366 |
32 | Spontaneous hematomas (HP:0007420) | 2.69528478 |
33 | Cerebral aneurysm (HP:0004944) | 2.67236370 |
34 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.64827531 |
35 | Amyloidosis (HP:0011034) | 2.63073366 |
36 | Orchitis (HP:0100796) | 2.60004409 |
37 | Hematochezia (HP:0002573) | 2.55162176 |
38 | Abnormal platelet volume (HP:0011876) | 2.52483393 |
39 | Recurrent skin infections (HP:0001581) | 2.52466273 |
40 | Gingivitis (HP:0000230) | 2.52372510 |
41 | Increased IgE level (HP:0003212) | 2.51530615 |
42 | Loss of speech (HP:0002371) | 2.47609579 |
43 | Colitis (HP:0002583) | 2.46035385 |
44 | Petechiae (HP:0000967) | 2.45585701 |
45 | Thrombocytosis (HP:0001894) | 2.45115797 |
46 | Episodic fever (HP:0001954) | 2.44120603 |
47 | T lymphocytopenia (HP:0005403) | 2.43895937 |
48 | Meningitis (HP:0001287) | 2.42799096 |
49 | Vasculitis (HP:0002633) | 2.42709024 |
50 | Hypochromic anemia (HP:0001931) | 2.42530857 |
51 | Abnormality of T cells (HP:0002843) | 2.39887677 |
52 | Abnormality of T cell number (HP:0011839) | 2.38503749 |
53 | Hypochromic microcytic anemia (HP:0004840) | 2.35522020 |
54 | Increased IgM level (HP:0003496) | 2.31502496 |
55 | Anorexia (HP:0002039) | 2.28284569 |
56 | Premature loss of primary teeth (HP:0006323) | 2.26823583 |
57 | Recurrent cutaneous fungal infections (HP:0011370) | 2.25234805 |
58 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.25234805 |
59 | Abnormality of T cell physiology (HP:0011840) | 2.24435637 |
60 | Periodontitis (HP:0000704) | 2.22194427 |
61 | Arterial thrombosis (HP:0004420) | 2.22091727 |
62 | Increased serum ferritin (HP:0003281) | 2.20845251 |
63 | Ulnar bowing (HP:0003031) | 2.20729531 |
64 | Purpura (HP:0000979) | 2.19859913 |
65 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.18269623 |
66 | Urticaria (HP:0001025) | 2.17202638 |
67 | Leukocytosis (HP:0001974) | 2.16816023 |
68 | Pulmonary embolism (HP:0002204) | 2.16806203 |
69 | Hepatosplenomegaly (HP:0001433) | 2.16156996 |
70 | Increased mean platelet volume (HP:0011877) | 2.15983715 |
71 | Aortic aneurysm (HP:0004942) | 2.15109642 |
72 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.13773267 |
73 | Osteolytic defects of the hand bones (HP:0009699) | 2.11961692 |
74 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.11961692 |
75 | Dysostosis multiplex (HP:0000943) | 2.11798814 |
76 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.11563868 |
77 | Chest pain (HP:0100749) | 2.11230279 |
78 | Optic neuritis (HP:0100653) | 2.09932912 |
79 | Retrobulbar optic neuritis (HP:0100654) | 2.09932912 |
80 | Sepsis (HP:0100806) | 2.09804840 |
81 | Osteomyelitis (HP:0002754) | 2.09374063 |
82 | Verrucae (HP:0200043) | 2.09314422 |
83 | Papilloma (HP:0012740) | 2.09314422 |
84 | Lymphopenia (HP:0001888) | 2.08975990 |
85 | Emphysema (HP:0002097) | 2.08674766 |
86 | Skin ulcer (HP:0200042) | 2.08388304 |
87 | Peritonitis (HP:0002586) | 2.06771700 |
88 | Malnutrition (HP:0004395) | 2.04469386 |
89 | Glomerulopathy (HP:0100820) | 2.03841440 |
90 | Prolonged bleeding time (HP:0003010) | 2.02611840 |
91 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.00414903 |
92 | Bicuspid aortic valve (HP:0001647) | 1.99659994 |
93 | Granulocytopenia (HP:0001913) | 1.97925233 |
94 | Systemic lupus erythematosus (HP:0002725) | 1.97602967 |
95 | Vacuolated lymphocytes (HP:0001922) | 1.96955926 |
96 | Persistence of primary teeth (HP:0006335) | 1.96901161 |
97 | Abnormal platelet function (HP:0011869) | 1.94436666 |
98 | Impaired platelet aggregation (HP:0003540) | 1.94436666 |
99 | Slow saccadic eye movements (HP:0000514) | 1.93009800 |
100 | Abnormality of iron homeostasis (HP:0011031) | 1.89804491 |
101 | Panhypogammaglobulinemia (HP:0003139) | 1.88731627 |
102 | Polygenic inheritance (HP:0010982) | 1.88332805 |
103 | Abnormality of the fingertips (HP:0001211) | 1.87846752 |
104 | Abnormality of the pleura (HP:0002103) | 1.86438116 |
105 | IgA deficiency (HP:0002720) | 1.84969887 |
106 | Microcytic anemia (HP:0001935) | 1.84836577 |
107 | Viral hepatitis (HP:0006562) | 1.84398530 |
108 | Gangrene (HP:0100758) | 1.83977451 |
109 | Protrusio acetabuli (HP:0003179) | 1.83812449 |
110 | Pulmonary infiltrates (HP:0002113) | 1.83668439 |
111 | Abnormality of the pericardium (HP:0001697) | 1.82845523 |
112 | Epistaxis (HP:0000421) | 1.81560764 |
113 | Gastrointestinal infarctions (HP:0005244) | 1.80922037 |
114 | Dilatation of the ascending aorta (HP:0005111) | 1.80888230 |
115 | Hemoptysis (HP:0002105) | 1.79567530 |
116 | Abnormality of the endocardium (HP:0004306) | 1.78346781 |
117 | Myocardial infarction (HP:0001658) | 1.78304466 |
118 | Gastrointestinal stroma tumor (HP:0100723) | 1.77980873 |
119 | Recurrent pneumonia (HP:0006532) | 1.76590123 |
120 | Subacute progressive viral hepatitis (HP:0006572) | 1.76561670 |
121 | Restrictive lung disease (HP:0002091) | 1.76051673 |
122 | Gingival bleeding (HP:0000225) | 1.74524173 |
123 | Fatigue (HP:0012378) | 1.73853474 |
124 | Aortic dissection (HP:0002647) | 1.72451824 |
125 | Cheilitis (HP:0100825) | 1.72357524 |
126 | Frequent falls (HP:0002359) | 1.72281237 |
127 | Eosinophilia (HP:0001880) | 1.71047437 |
128 | Combined immunodeficiency (HP:0005387) | 1.70717993 |
129 | Basal cell carcinoma (HP:0002671) | 1.69939728 |
130 | Polycythemia (HP:0001901) | 1.68319239 |
131 | Cervical subluxation (HP:0003308) | 1.66909207 |
132 | Mitral valve prolapse (HP:0001634) | 1.66710054 |
133 | Increased cerebral lipofuscin (HP:0011813) | 1.66040489 |
134 | Agammaglobulinemia (HP:0004432) | 1.65789019 |
135 | Radial bowing (HP:0002986) | 1.65374438 |
136 | Thin bony cortex (HP:0002753) | 1.62901845 |
137 | Abnormality of the peritoneum (HP:0002585) | 1.62889153 |
138 | Hypergammaglobulinemia (HP:0010702) | 1.62397006 |
139 | Hyperacusis (HP:0010780) | 1.59841464 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 3.98141574 |
2 | TRIB3 | 3.11066071 |
3 | PRPF4B | 2.84619238 |
4 | PKN2 | 2.74227362 |
5 | STK10 | 2.69722546 |
6 | EEF2K | 2.61974658 |
7 | MAP3K10 | 2.61247948 |
8 | ERN1 | 2.43614638 |
9 | LRRK2 | 2.04868302 |
10 | JAK3 | 2.03154026 |
11 | TYK2 | 2.01100383 |
12 | EPHB1 | 1.95568069 |
13 | ZAP70 | 1.91935176 |
14 | GRK6 | 1.91801947 |
15 | BLK | 1.91370107 |
16 | TBK1 | 1.90376695 |
17 | TTN | 1.82398147 |
18 | CSK | 1.74807666 |
19 | SMG1 | 1.72392977 |
20 | TAOK2 | 1.71139154 |
21 | CDK12 | 1.67904333 |
22 | TXK | 1.66507273 |
23 | TNK2 | 1.61941059 |
24 | MAP3K14 | 1.61472269 |
25 | PTK6 | 1.60086177 |
26 | IRAK4 | 1.54917902 |
27 | BTK | 1.49056764 |
28 | MAP2K3 | 1.46234299 |
29 | RPS6KA4 | 1.42615062 |
30 | IKBKE | 1.40802637 |
31 | PAK4 | 1.40312702 |
32 | MAP3K1 | 1.38789731 |
33 | FGFR4 | 1.35760466 |
34 | SIK3 | 1.31885885 |
35 | TESK2 | 1.31857270 |
36 | ITK | 1.31407518 |
37 | MST4 | 1.30333058 |
38 | TGFBR2 | 1.29346778 |
39 | HCK | 1.22434564 |
40 | JAK1 | 1.21945537 |
41 | KDR | 1.18113753 |
42 | PIM1 | 1.16051900 |
43 | IKBKB | 1.15826359 |
44 | CSF1R | 1.14295949 |
45 | KIT | 1.11373003 |
46 | IRAK3 | 1.09090683 |
47 | RPS6KB2 | 1.07404925 |
48 | FGFR3 | 1.06701191 |
49 | BMX | 1.06262176 |
50 | NEK2 | 1.05377969 |
51 | RIPK1 | 1.05285506 |
52 | CDC42BPA | 1.04986810 |
53 | LCK | 1.03072234 |
54 | PRKD2 | 1.02579857 |
55 | TESK1 | 1.01933882 |
56 | MAP3K8 | 1.01534324 |
57 | MARK3 | 0.98832117 |
58 | IRAK2 | 0.98769642 |
59 | MAP3K11 | 0.97407701 |
60 | MAP3K3 | 0.94138279 |
61 | CHUK | 0.93882946 |
62 | FLT3 | 0.93439321 |
63 | YES1 | 0.92721410 |
64 | CLK1 | 0.91872262 |
65 | SYK | 0.91652404 |
66 | MARK2 | 0.91202418 |
67 | IRAK1 | 0.89177266 |
68 | PDPK1 | 0.86037872 |
69 | TRPM7 | 0.85059971 |
70 | FGR | 0.83746277 |
71 | PIM2 | 0.81921306 |
72 | CDK4 | 0.81246844 |
73 | NME2 | 0.79386511 |
74 | CDK6 | 0.79167635 |
75 | TEC | 0.78816804 |
76 | DMPK | 0.77185759 |
77 | RIPK4 | 0.76621089 |
78 | TAOK1 | 0.76550168 |
79 | PDK1 | 0.75730053 |
80 | EPHA2 | 0.75056347 |
81 | MAP3K6 | 0.74684082 |
82 | SCYL2 | 0.74009684 |
83 | BMPR2 | 0.72637821 |
84 | JAK2 | 0.72354922 |
85 | PTK2 | 0.65884599 |
86 | MATK | 0.65787478 |
87 | MAPKAPK3 | 0.64768906 |
88 | TGFBR1 | 0.64560216 |
89 | MAP2K2 | 0.63907657 |
90 | LYN | 0.62929055 |
91 | MAPKAPK2 | 0.61089109 |
92 | EPHA3 | 0.60612402 |
93 | SIK2 | 0.60527844 |
94 | MAP3K5 | 0.60170243 |
95 | PDGFRA | 0.59934907 |
96 | FES | 0.59326727 |
97 | STK4 | 0.55346112 |
98 | ILK | 0.54217141 |
99 | PAK2 | 0.52367815 |
100 | FYN | 0.51418648 |
101 | STK3 | 0.51026446 |
102 | RPS6KA6 | 0.50264817 |
103 | MTOR | 0.49608896 |
104 | MOS | 0.49580143 |
105 | MAP3K2 | 0.49395291 |
106 | MAPK12 | 0.49113154 |
107 | HIPK2 | 0.48998892 |
108 | PDGFRB | 0.48323207 |
109 | MAPK7 | 0.47535464 |
110 | SIK1 | 0.47125650 |
111 | RPS6KA2 | 0.46676164 |
112 | EGFR | 0.46663280 |
113 | RPS6KL1 | 0.45668080 |
114 | RPS6KC1 | 0.45668080 |
115 | PTK2B | 0.43867219 |
116 | NEK9 | 0.41511695 |
117 | MAP3K7 | 0.41029248 |
118 | NLK | 0.40950352 |
119 | MAP3K13 | 0.39655514 |
120 | RET | 0.39565880 |
121 | CDK19 | 0.38123344 |
122 | ABL1 | 0.37626798 |
123 | GRK7 | 0.37519245 |
124 | TAOK3 | 0.37136921 |
125 | ICK | 0.35883848 |
126 | STK38 | 0.35864848 |
127 | DYRK1B | 0.35856421 |
128 | MELK | 0.35708951 |
129 | KSR2 | 0.34620568 |
130 | CDK9 | 0.34473957 |
131 | STK24 | 0.34074769 |
132 | RAF1 | 0.32961593 |
133 | SGK3 | 0.32316614 |
134 | PIK3CG | 0.31720296 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.77357771 |
2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.18939126 |
3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.17812904 |
4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.13322892 |
5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.11651429 |
6 | Measles_Homo sapiens_hsa05162 | 1.85961880 |
7 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.85428013 |
8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.83462577 |
9 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.75684829 |
10 | Shigellosis_Homo sapiens_hsa05131 | 1.74718532 |
11 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.73488659 |
12 | * Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.70937934 |
13 | * Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.69734008 |
14 | Legionellosis_Homo sapiens_hsa05134 | 1.69553251 |
15 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.66154785 |
16 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.63328399 |
17 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.61434799 |
18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.59161578 |
19 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.56312970 |
20 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.55712487 |
21 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.55593699 |
22 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.51432133 |
23 | Apoptosis_Homo sapiens_hsa04210 | 1.48852485 |
24 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.48605983 |
25 | Viral myocarditis_Homo sapiens_hsa05416 | 1.48570962 |
26 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.48371734 |
27 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.43845731 |
28 | Malaria_Homo sapiens_hsa05144 | 1.42643992 |
29 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.41408270 |
30 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.39108757 |
31 | Tuberculosis_Homo sapiens_hsa05152 | 1.38258856 |
32 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.36921050 |
33 | Hepatitis B_Homo sapiens_hsa05161 | 1.36717742 |
34 | Influenza A_Homo sapiens_hsa05164 | 1.36099959 |
35 | Pertussis_Homo sapiens_hsa05133 | 1.35985678 |
36 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.34240934 |
37 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.33675879 |
38 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.32804739 |
39 | Asthma_Homo sapiens_hsa05310 | 1.31835071 |
40 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.31433869 |
41 | Salmonella infection_Homo sapiens_hsa05132 | 1.30240464 |
42 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.30049380 |
43 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.29377942 |
44 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.26753158 |
45 | Allograft rejection_Homo sapiens_hsa05330 | 1.19683732 |
46 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.17882790 |
47 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.13417341 |
48 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.12851427 |
49 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.08625977 |
50 | HTLV-I infection_Homo sapiens_hsa05166 | 1.02512572 |
51 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.01451213 |
52 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.99931687 |
53 | Adherens junction_Homo sapiens_hsa04520 | 0.98405555 |
54 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.98077252 |
55 | * Platelet activation_Homo sapiens_hsa04611 | 0.97192150 |
56 | Amoebiasis_Homo sapiens_hsa05146 | 0.96888347 |
57 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.96536708 |
58 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.95709958 |
59 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.95573330 |
60 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.94544780 |
61 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.94387443 |
62 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.94154730 |
63 | Hepatitis C_Homo sapiens_hsa05160 | 0.93916421 |
64 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.91380234 |
65 | Bladder cancer_Homo sapiens_hsa05219 | 0.90297408 |
66 | Colorectal cancer_Homo sapiens_hsa05210 | 0.89673921 |
67 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.88038561 |
68 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.83184570 |
69 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.82346055 |
70 | * Focal adhesion_Homo sapiens_hsa04510 | 0.82191454 |
71 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.81942186 |
72 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.81684569 |
73 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.81462386 |
74 | Other glycan degradation_Homo sapiens_hsa00511 | 0.73667591 |
75 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.73121871 |
76 | Ribosome_Homo sapiens_hsa03010 | 0.70118738 |
77 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.69380894 |
78 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.69154824 |
79 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.66313472 |
80 | DNA replication_Homo sapiens_hsa03030 | 0.65938401 |
81 | Insulin resistance_Homo sapiens_hsa04931 | 0.64799061 |
82 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.63414889 |
83 | Endocytosis_Homo sapiens_hsa04144 | 0.61149386 |
84 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.59526900 |
85 | Thyroid cancer_Homo sapiens_hsa05216 | 0.59139529 |
86 | Endometrial cancer_Homo sapiens_hsa05213 | 0.58741746 |
87 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.57979546 |
88 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.57703636 |
89 | Lysosome_Homo sapiens_hsa04142 | 0.57380033 |
90 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.56734406 |
91 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.56524105 |
92 | Pathways in cancer_Homo sapiens_hsa05200 | 0.55731805 |
93 | Prostate cancer_Homo sapiens_hsa05215 | 0.55360893 |
94 | Base excision repair_Homo sapiens_hsa03410 | 0.55202993 |
95 | Spliceosome_Homo sapiens_hsa03040 | 0.54357853 |
96 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.52289724 |
97 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.50102418 |
98 | Cell cycle_Homo sapiens_hsa04110 | 0.49623356 |
99 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.48994120 |
100 | Galactose metabolism_Homo sapiens_hsa00052 | 0.48963856 |
101 | Prion diseases_Homo sapiens_hsa05020 | 0.47576034 |
102 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.46975497 |
103 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.46925769 |
104 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.46279366 |
105 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.44777830 |
106 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.44105111 |
107 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43260690 |
108 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.43180042 |
109 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.42488201 |
110 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.41840532 |
111 | Phagosome_Homo sapiens_hsa04145 | 0.41662381 |
112 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.40723817 |
113 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.40149650 |
114 | RNA transport_Homo sapiens_hsa03013 | 0.40074579 |
115 | * Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.40016112 |